Charles River, WuXi PharmaTech CEOs Issue Joint Appeal For Shareholder Support For Deal
This article was originally published in PharmAsia News
Executive Summary
BEIJING - The heads of the Massachusetts-based Charles River Laboratories and the Shanghai-headquartered WuXi PharmaTech issued a joint appeal calling for shareholders to rally in support of the proposed union of the two contract research organizations during near-simultaneous votes four weeks from now